Catalyst Wire Dossier Catalyst Wire Dossier

BCD-055

infliximab biosimilar · Biocad
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for BCD-055, covering 2016-06-08 to 2019-06-14. Get the full timeline:

Most recent: Clinical Trial Update: Comparative Clinical Trial of Efficacy and Safety of BCD-055 and Remicade® in Combination With Methotrexate in Patients With Active Rheumatoid Arthritis [Phase 3]

See pricing